Tvardi Therapeutics's total assets for Q2 2026 were $17.52M, a decrease of -45.38% from the previous quarter. CH:TVRD total liabilities were $9.13M for the fiscal quarter, a -17.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.